{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:22:57Z","timestamp":1790101377268,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.anndiagpath.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T10:45:18Z","timestamp":1486637118000},"page":"12-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor"],"prefix":"10.1016","volume":"28","author":[{"given":"Anastasia M.","family":"Konstantinova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Vanecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Martinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubov","family":"Kyrpychova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic V.","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Portelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry V.","family":"Kazakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00000372-199113060-00006","article-title":"Anogenital \u201csweat\u201d glands. Histology and pathology of a gland that may mimic mammary glands","volume":"13","author":"Van der Putte","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00004347-199404000-00009","article-title":"Mammary-like glands of the vulva and their disorders","volume":"13","author":"Van der Putte","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.dad.0000194052.65695.f1","article-title":"Vulvar toker cells: the long-awaited missing link: a proposal for an origin-based histogenetic classification of extramammary Paget disease","volume":"28","author":"Belousova","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/01.pas.0000164346.61765.9d","article-title":"Pseudoangiomatous stromal hyperplasia in lesions involving anogenital mammary-like glands","volume":"29","author":"Kazakov","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0303-6987.2006.00391.x","article-title":"Adenosis tumor of anogenital mammary-like glands: a case report and demonstration of clonality by HUMARA assay","volume":"33","author":"Kazakov","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.dad.0000183890.09480.d9","article-title":"Unusual hyperplasia of anogenital mammary-like glands","volume":"28","author":"Kazakov","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/DAD.0000000000000498","article-title":"Bilateral gigantomastia, multiple synchronous nodular pseudoangiomatous stromal hyperplasia involving breast and bilateral axillary accessory breast tissue, and perianal mammary-type hamartoma of anogenital mammary-like glands: a case report","volume":"38","author":"Hayes","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0040","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/DAD.0b013e318284860c","article-title":"A tumoriform lesion of the vulva with features of mammary-type fibrocystic disease","volume":"35","author":"Konstantinova","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/DAD.0000000000000495","article-title":"Hidradenoma papilliferum: a clinicopathologic study of 264 tumors from 261 patients, with emphasis on mammary-type alterations","volume":"38","author":"Konstantinova","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0050","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1600-0560.2009.01250.x","article-title":"Pseudoangiomatous stromal hyperplasia in a complex neoplastic lesion involving anogenital mammary-like glands","volume":"36","author":"Vazmitel","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/DAD.0b013e31817c6a7d","article-title":"Hidradenoma papilliferum with a ductal carcinoma in situ component: case report and review of the literature","volume":"30","author":"Vazmitel","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/DAD.0000000000000744","article-title":"Anogenital mammary-like glands: a study of their normal histology with emphasis on glandular depth, presence of columnar epithelial cells, and distribution of elastic fibers","author":"Konstantinova","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ajcp\/37.2.182","article-title":"Hidradenoma papilliferum","volume":"37","author":"Meeker","year":"1962","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.dad.0000154400.45465.a7","article-title":"Hidradenoma papilliferum with oxyphilic metaplasia: a clinicopathological study of 18 cases, including detection of human papillomavirus","volume":"27","author":"Kazakov","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000372-200608000-00005","article-title":"Mitotic count is not predictive of clinical behavior in hidradenoma papilliferum of the vulva: a clinicopathologic study of 19 cases","volume":"28","author":"Sington","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00313020902884493","article-title":"Mammary-like gland adenoma of the vulva: review of 46 cases","volume":"41","author":"Scurry","year":"2009","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/PAS.0b013e3181c6e5c5","volume":"34","author":"Kazakov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0090","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/DAD.0b013e31828742e4","article-title":"A composite neoplastic lesion of the vulva with mixed features of fibroadenoma and hidradenoma papilliferum combined with pseudoangiomatous stromal hyperplasia containing multinucleated giant cells","volume":"36","author":"Konstantinova","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0095","article-title":"Study of selected BRCA1, BRCA2 and PIK3CA mutations in benign and malignant lesions of anogenital mammary-like glands","author":"Konstantinova","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0100","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10549-015-3469-1","article-title":"Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing","volume":"152","author":"Mishima","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAP.0b013e318202eba5","article-title":"Lesions of anogenital mammary-like glands: an update","volume":"18","author":"Kazakov","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0115","article-title":"PIK3CA and AKT1 mutations in hidradenoma papilliferum","author":"Goto","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humpath.2016.04.014","article-title":"Frequent PIK3CA-activating mutations in hidradenoma papilliferums","volume":"55","author":"Liau","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/gcc.22315","article-title":"Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma","volume":"55","author":"Pfarr","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0092-8674(92)90166-A","article-title":"Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit","volume":"70","author":"Hiles","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","article-title":"Mutation of the PIK3CA oncogene in human cancers","volume":"94","author":"Karakas","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0888-7543(88)90114-0","article-title":"The AKT1 proto-oncogene maps to human chromosome 14, band q32","volume":"2","author":"Staal","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Troxell","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0150","first-page":"895151","article-title":"Metastatic extramammary Paget's disease of scrotum responds completely to single agent trastuzumab in a hemodialysis patient: case report, molecular profiling and brief review of the literature","volume":"2015","author":"Barth","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0155","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/modpathol.2012.65","article-title":"Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease","volume":"25","author":"Kang","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0160","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ijc.27738","article-title":"Oncogenic mutations in extramammary Paget's disease and their clinical relevance","volume":"132","author":"Kang","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/gcc.22396","article-title":"Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway","volume":"56","author":"Volckmar","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0170","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/modpathol.2016.97","article-title":"Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase\/RAS signaling pathways and provides insights into intratumoral heterogeneity","volume":"29","author":"Liu","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.3409","article-title":"Genomic landscapes of breast fibroepithelial tumors","volume":"47","author":"Tan","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0180","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.bjc.6604212","article-title":"Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias","volume":"98","author":"Kim","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-009-0406-1","article-title":"Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma","volume":"120","author":"Dunlap","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0190","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4161\/cbt.3.8.994","article-title":"The PIK3CA gene is mutated with high frequency in human breast cancers","volume":"3","author":"Bachman","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0195","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.onc.1210202","article-title":"The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer","volume":"26","author":"Dillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0200","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-07-6854","article-title":"An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer","volume":"68","author":"Stemke-Hale","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00428-016-1938-5","article-title":"Mutation of genes of the PI3K\/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness","volume":"469","author":"Tserga","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0210","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0215","first-page":"57","article-title":"Uncovering the role of p53 splice variants in human malignancy: a clinical perspective","volume":"7","author":"Surget","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3563","article-title":"Role of ABL family kinases in cancer: from leukaemia to solid tumours","volume":"13","author":"Greuber","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0225","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-3-642-60393-8_26","article-title":"P53 gene alterations in human tumors: perspectives for cancer control","volume":"143","author":"Hollstein","year":"1997","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1158\/1541-7786.MCR-14-0578","article-title":"Next-gen sequencing exposes frequent MED12 mutations and actionable therapeutic targets in phyllodes tumors","volume":"13","author":"Cani","year":"2015","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0235","first-page":"4092","article-title":"TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution","volume":"61","author":"Greenblatt","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0240","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.semcdb.2011.07.022","article-title":"Interactions between subunits of the mediator complex with gene-specific transcription factors","volume":"22","author":"Borggrefe","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0245","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.semcdb.2011.07.024","article-title":"Mediator and human disease","volume":"22","author":"Spaeth","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0250","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/his.12712","article-title":"MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast","volume":"67","author":"Piscuoglio","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0255","doi-asserted-by":"crossref","first-page":"84428","DOI":"10.18632\/oncotarget.12991","article-title":"MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways","volume":"7","author":"Lae","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0260","doi-asserted-by":"crossref","first-page":"18714","DOI":"10.1074\/jbc.M302243200","article-title":"Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4\/DPC4","volume":"278","author":"Lin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0265","first-page":"2527","article-title":"DPC4 gene in various tumor types","volume":"56","author":"Schutte","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0270","first-page":"2578","article-title":"Frequency of Smad gene mutations in human cancers","volume":"57","author":"Riggins","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/geno.1996.4482","article-title":"Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes","volume":"39","author":"Andre","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0280","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.biocel.2006.12.005","article-title":"c-Kit\u2014a hematopoietic cell essential receptor tyrosine kinase","volume":"39","author":"Edling","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0285","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.4161\/cc.7.18.6752","article-title":"Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation","volume":"7","author":"Ray","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0290","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/modpathol.2008.78","article-title":"Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon","volume":"21","author":"Djordjevic","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0295","first-page":"4280","article-title":"C-kit and PDGFRA gene mutations in triple negative breast cancer","volume":"7","author":"Zhu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0300","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0305","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1006\/bbrc.1993.2392","article-title":"Exon structure and flanking intronic sequences of the human RET proto-oncogene","volume":"196","author":"Ceccherini","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0310","doi-asserted-by":"crossref","first-page":"33577","DOI":"10.1074\/jbc.M605604200","article-title":"Structure and chemical inhibition of the RET tyrosine kinase domain","volume":"281","author":"Knowles","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0315","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2005.05.010","article-title":"RET tyrosine kinase signaling in development and cancer","volume":"16","author":"Arighi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020353","article-title":"RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A\/familial medullary thyroid carcinoma family","volume":"6","author":"Qi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-015-3662-2","article-title":"Screening for germline mutations in breast\/ovarian cancer susceptibility genes in high-risk families in Israel","volume":"155","author":"Yablonski-Peretz","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00292-014-1984-1","article-title":"Morphological and genetic aspects of Spitz tumors","volume":"36","author":"Wiesner","year":"2015","journal-title":"Pathologe"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0335","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2011.196","article-title":"Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal","volume":"25","author":"Miller","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0340","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0960-9822(00)80021-4","article-title":"A family of mammalian F-box proteins","volume":"9","author":"Winston","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0350","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.humpath.2014.10.014","article-title":"Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma","volume":"46","author":"Muller","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0355","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/bcr2788","article-title":"Inactivation of FBXW7\/hCDC4-beta expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer","volume":"12","author":"Akhoondi","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0360","doi-asserted-by":"crossref","first-page":"dju107","DOI":"10.1093\/jnci\/dju107","article-title":"FBXW7 mutations in melanoma and a new therapeutic paradigm","volume":"106","author":"Aydin","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0365","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng.3525","article-title":"Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma","volume":"48","author":"Bonilla","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2017.02.004_bb0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2016","journal-title":"Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913417300412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913417300412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T09:38:23Z","timestamp":1568799503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913417300412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":74,"alternative-id":["S1092913417300412"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.02.004","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}